Outlook Therapeutics, Inc.
OTLK · NASDAQ
9/30/2025 | 9/30/2024 | 9/30/2023 | 9/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$62,424,863 | -$75 | -$59 | -$66 |
| Dep. & Amort. | $117,052 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $8,897,887 | $5 | $6 | $8 |
| Change in WC | $0 | -$3 | $5 | -$2 |
| Other Non-Cash | $1,580,487 | $4 | $6 | $3 |
| Operating Cash Flow | -$51,829,437 | -$69 | -$43 | -$57 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$0 | $20 | -$2 |
| Stock Issued | $25,396,398 | $60 | $30 | $62 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $44,984,984 | $0 | -$1 | -$0 |
| Financing Cash Flow | $44,984,984 | $60 | $49 | $60 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$6,844,453 | -$8 | $6 | $3 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $14,927,538 | $23 | $17 | $14 |
| End Cash | $8,083,085 | $15 | $23 | $17 |
| Free Cash Flow | -$51,829,437 | -$69 | -$43 | -$57 |